Gluathoine Depletion may not be the sole factor, I don't think we know that yet. There are over 7,000 studies of glutathione, and 90,000 studies that mention the word, clearly it is involved in many conditions. Also, glutathione can be depleted in specific organ systems I believe including just in the brain. So there may be a complex interaction between GD and various co-morbid conditions. Also, the degree of depletion may vary, the SNPs of the patient and also the existing viral load figure in to whether or not a given level of depletion will lead to viral re-activation, methylation cycle blocks, or some other problem due to the oxidative stress level. Without pre-activated bad SNPs a person may tolerate much more glutathione depletion. Maybe a virus or retrovirus plays a role in activating bad SNPs, much more research is needed.
Glutathione in supplement form is not the solution, the methylation cycle has to be corrected so the cells can produce their own, so specific activated supplements may help differentially depending on specific pathologies and interactions between them.
The Reno GD-MB study needs to be validated with other studies, too early to say whether it can generalize, this is a recent report, in 2009. So not correct to say it can't be generalized, at least not yet.
The blocks are more complicated than just NO, I don't know all the details, but there are many different steps in the cycle that can be broken. Heavy metal load is a common block, for example. What can be easily blocked depends on one's specific SNPs and also the biochemistry of the total load on the system.
I have not studied how XMRV blocks CREB but thought the specific attachment location was still unknown, although you have made an interesting connection, with the NOS upregulation. If that is a high-level factor and XMRV is involved, then improving glutathione metabolism becomes an important part of the treatment of XMRV related disease. And given that we already know this may be important for ME/CFS, maybe glutathione load/block is a good direction to focus on for treatments, regardless of the future outcome of the XMRV hypothesis.